Companies researching Xtandi (Enzalutamide)

Enzalutamide, marketed under the brand name Xtandi, is a nonsteroidal antiandrogen drug used to treat prostate cancer.

List of companies that research Xtandi (Enzalutamide)

This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →

CompanyCountryIndustryEmployeesRevenueTechnologies
Country flag

Japan

Pharmaceutical Manufacturing

12k

Xtandi (Enzalutamide)

Country flag

United Kingdom

Research Services

1.6k

$35M

Xtandi (Enzalutamide)

Country flag

Brazil

Pharmaceutical Manufacturing

10k

Xtandi (Enzalutamide)

Country flag

United States

IT Services and IT Consulting

54

Xtandi (Enzalutamide)

Showing top companies out of 7 that research Xtandi (Enzalutamide). Get the full list on TheirStack.

Frequently asked questions